We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current MCRXF market cap is 30.79M. The company's latest EPS is AUD -0.0174 and P/E is -3.45.
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 7.55M | 6.78M | 13.09M | 22.33M | 21.93M |
| Operating Income | -9.22M | -14.06M | -16.81M | -10.55M | -9.55M |
| Net Income | -10.07M | -14.73M | -17.09M | -10.75M | -9.77M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 33.7M | 44.68M | 31.28M | 30.3M | 26.9M |
| Total Liabilities | 18.8M | 10.47M | 11.99M | 13.11M | 12.63M |
| Total Equity | 14.9M | 34.21M | 19.29M | 17.19M | 14.26M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -9.46M | -9.86M | -18.11M | -10.99M | -6.44M |
| Investing | -2.2M | -901k | -1.11M | -779k | -369k |
| Financing | 28.37M | 22.58M | -612k | 6.69M | 4.81M |
| Market Cap | 30.79M |
| Price to Earnings Ratio | -3.45 |
| Price to Sales Ratio | 1.53 |
| Price to Cash Ratio | 10.34 |
| Price to Book Ratio | 2.36 |
| Dividend Yield | - |
| Shares Outstanding | 559.87M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -42.11% |
| 52 Week High | 0.11 |
| 52 Week Low | 0.03 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Micro X Ltd (PK) |
| Address |
a14 adelaide, south australia 5042 |
| Website | https://www.micro-x.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
